CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: NASDAQ:), a number one regenerative drugs firm centered on the event, manufacture, and commercialization of product options for the Superior Wound Care and Surgical & Sports activities Medication markets, immediately introduced that administration will take part within the Truist Securities MedTech Convention, which is being held on the InterContinental Boston in Boston, MA on Tuesday, June 18th. Administration will take part in 1×1 conferences. There might be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a number one regenerative drugs firm centered on the event, manufacture, and commercialization of options for the superior wound care and surgical and sports activities drugs markets. Organogenesis presents a complete portfolio of progressive regenerative merchandise to handle affected person wants throughout the continuum of care. For extra data, go to www.organogenesis.com.